Goldman Sachs Group Inc Silverback Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 462,716 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
462,716
Previous 141,101 227.93%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
N/A
321,615 Added 227.93%
462,716 $0
Q4 2023

Feb 13, 2024
SELL
N/A
-98,347 Reduced 41.07%
141,101 $0
Q3 2023

May 14, 2024
BUY
N/A
98,347 Added 69.7%
239,448 $0
Q3 2023

Nov 14, 2023
BUY
N/A
116,295 Added 94.43%
239,448 $0
Q2 2023

May 14, 2024
SELL
N/A
-73,351 Reduced 37.33%
123,153 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-73,351 Reduced 37.33%
123,153 $0
Q1 2023

May 14, 2024
BUY
N/A
83,609 Added 74.06%
196,504 $0
Q1 2023

May 11, 2023
BUY
N/A
83,609 Added 74.06%
196,504 $0
Q4 2022

May 14, 2024
BUY
$0.0 - $6.07 $0 - $80,385
13,243 Added 13.29%
112,895 $0
Q4 2022

Feb 13, 2023
BUY
$0.0 - $6.07 $0 - $80,385
13,243 Added 13.29%
112,895 $0
Q3 2022

May 14, 2024
SELL
$3.91 - $5.52 $92,408 - $130,459
-23,634 Reduced 19.17%
99,652 $526,000
Q3 2022

Nov 10, 2022
SELL
$3.91 - $5.52 $92,408 - $130,459
-23,634 Reduced 19.17%
99,652 $0
Q2 2022

May 14, 2024
SELL
$2.9 - $4.44 $51,663 - $79,098
-17,815 Reduced 12.63%
123,286 $523,000
Q2 2022

Aug 15, 2022
BUY
$2.9 - $4.44 $62,625 - $95,881
21,595 Added 21.24%
123,286 $523,000
Q1 2022

May 16, 2022
BUY
$3.51 - $6.74 $82,337 - $158,106
23,458 Added 29.98%
101,691 $357,000
Q4 2021

Feb 14, 2022
BUY
$6.03 - $11.67 $144,020 - $278,726
23,884 Added 43.95%
78,233 $521,000
Q3 2021

Nov 10, 2021
BUY
$9.98 - $35.22 $542,403 - $1.91 Million
54,349 New
54,349 $543,000

Others Institutions Holding SBTX

# of Institutions
117
Shares Held
47.9M
Call Options Held
442K
Put Options Held
42K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email